Perth, June 14, 2017 AEST (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or "the Company") is pleased to announce the appointment of Lisa Dea as Chief Financial Officer ("CFO") of the Company effective immediately. Ms. Dea has also been appointed CFO of Harvest One Cannabis Inc. ("Harvest One") (CVE:HVST), and replaces Mr Kwong Choo, who will be assuming a new role as Vice President Finance of Harvest One.

Ms. Dea has over 20 years of experience in the finance, securities and accounting fields, having been the CFO of several ASX, TSX and TSXV listed and dual listed companies including Kabuni Limited (ASX:WNH), El Tigre Silver Corporation (CVE:ELS) and Greenbriar Capital Corporation (CVE:GRB).

In these roles Ms. Dea was responsible for corporate strategy, all aspects of finance and legal, debt and capital market activities, internal and external public reporting, financial controls, processes and corporate governance.

Ms. Dea has been instrumental in helping several companies grow from the development stage to large-scale commercial operations. Prior to her time in industry, Lisa spent eleven years at Deloitte & Touche LLP, achieving the position of Senior Manager. Ms. Dea obtained her Chartered Accountants designation in 1997 and also holds a BComm from the University of British Columbia.

Managing Director of MMJ PhytoTech Andreas Gedeon, commented:

"We are very pleased to welcome someone of Lisa's caliber to the Company. Lisa brings a wealth of financial and strategic experience from several publically listed companies and will be extremely beneficial for the Company as we continue to execute on our growth strategy.

"Lisa is the final appointment at a corporate level and I am very confident we have assembled an extremely qualified executive team over the last few months to advance the Company's plans in the future."


About MMJ PhytoTech Ltd

Phytotech Medical ASX:PYL

MMJ PhytoTech Limited (ASX:MMJ) is focused on becoming a large-scale cannabis producer, targeting direct supply to the growing Canadian medical and recreational markets which will have an estimated combined value of C$8-9 billion by 2024.

The Company controls operations across the entire medicinal cannabis value chain through its ~59% interest in TSX-V listed Harvest One Cannabis Inc (CVE:HVST) and its 100% interest in Israeli research and development subsidiary, PhytoTech Therapeutics Ltd, both of which are strategically located in favourable jurisdictions with supportive regulatory frameworks in place.

      


Contact

Andreas Gedeon
Managing Director
Phone: +1-250-713-6302
Email: agedeon@mmj.ca
www.mmjphytotech.com.au



Related Companies

MMJ PhytoTech Ltd   
Kabuni Ltd
Harvest One Cannabis Inc
Greenbriar Capital Corp
El Tigre Silver Corp

ABN Newswire This Page Viewed:  (Last 7 Days: 65) (Last 30 Days: 269) (Since Published: 2350) 
ANALYTICS: LOGIN HERE

MMJ PhytoTech Ltd NEWS: RECENT VISITS (14210)

Research Report

Social Media